 |
|
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
|
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
|
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
 |
Synopsis for November 8, 2002
The MMWR is embargoed until 12 Noon ET, Thursdays.
- Adverse Events Associated With 17D-Derived Yellow Fever Vaccination -- United States, 2001-2002
- Vaginal Birth After Cesarean Birth -- California 1996-2000
- Global Progress Toward Laboratory Containment of Wild Polioviruses -- July 2001-August 2002
- West Nile Virus Activity -- United States, October 31-November 6, 2002
MMWR Reports and Recommendations
November 8, 2002/Vol 51/ No. 17
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002
This report updates CDC's recommendations for the use of yellow fever vaccine.
Contact: Martin Cetron, MD
CDC, National Center for Infectious Diseases
(404) 498-1600
| No telebriefing is scheduled for November 7, 2002 |
|
Synopsis for November 8, 2002
Adverse Events Associated With 17D-Derived Yellow Fever Vaccination -- United States, 2001-2002
Yellow fever vaccination is still recommended for persons aged >9 months traveling to countries where yellow fever is endemic or
epidemic.
PRESS CONTACT:
Martin Cetron, MD
CDC, National Center for Infectious Diseases
(404) 498鈥?600 |
|
Between May 2001- October 2002, CDC received reports of six cases of serious neurologic (4) and systemic (2) adverse events associated with
yellow fever vaccination. These events are rare. Clinicians are encouraged to report to the Vaccine Adverse Event Reporting System patients with
fever (>24 hours) or systemic illness within 30 days following vaccination. Despite these rare case reports, yellow fever is an important
vaccine-preventable disease among travelers to, and those living in, the tropics of Africa and South America. Because of potential for high risk
exposure to and severity of yellow fever infection, and the availability of an efficacious vaccine, ACIP and CDC continue to recommend yellow
fever vaccination for persons aged >9 months traveling to countries where yellow fever is endemic or epidemic.
Vaginal Birth After Cesarean Birth -- California 1996-2000
PRESS CONTACT:
Sharon Durousseau
CDC, Epidemiology Program Office
(510) 784鈥?794 (California) |
|
Summary Not Available.
Global Progress Toward Laboratory Containment of Wild Polioviruses -- July 2001-August 2002
There has been substantial progress in identifying laboratories with wild poliovirus materials and in conducting national wild poliovirus
inventories.
PRESS CONTACT:
Division of Media Relations
CDC, Office of Communication
(404) 639-3286 |
|
Since the World Health Assembly resolved in 1988 to eradicate poliomyelitis, the number of countries in which wild poliovirus is endemic has
decreased from 125 to 10 in 2001. The Global Commission for the Certification of the Eradication of Poliomyelitis will declare the world
polio-free when all regions have documented the absence of wild poliovirus transmission for at least 3 consecutive years and when laboratories
with wild poliovirus materials have implemented appropriate containment conditions. This report describes preparations for laboratory
containment, creation of a global inventory of laboratories and institutions retaining wild poliovirus, and summarizes global progress since
July 2001. The data indicate that there has been substantial progress in identifying laboratories with wild poliovirus materials and in
conducting national wild poliovirus inventories.
West Nile Virus Activity -- United States, October 31-November 6, 2002
PRESS CONTACT:
Division of Media Relations
CDC, Office of Communication
(404) 639-3286 |
|
Summary Not Available.
|
